114 results
Page 4 of 6
8-K
EX-1.1
hn4frt4fk7w2
19 Feb 21
Entry into a Material Definitive Agreement
4:13pm
424B5
lezx14r
19 Feb 21
Prospectus supplement for primary offering
4:12pm
8-K
EX-1.1
mvrom
18 Dec 20
ENDRA Life Sciences Announces Proposed Public Offering of Common Stock
5:04pm
424B5
c41i28576zfspkhcjgh
17 Dec 20
Prospectus supplement for primary offering
5:17pm
424B5
i8y36pmits 8j
15 Dec 20
Prospectus supplement for primary offering
5:04pm
8-K
EX-99.1
p2wk6vrpzee4qiur
16 Nov 20
ENDRA Life Sciences Reports Third Quarter 2020 Financial Results and Provides Business Update
4:05pm
8-K
EX-1.1
d5i5 y0mt9wz
25 Sep 20
Entry into a Material Definitive Agreement
4:54pm
424B5
zm3w2knsep ek
25 Sep 20
Prospectus supplement for primary offering
4:53pm
8-K
EX-99.1
omyuc301
14 May 20
ENDRA Life Sciences Provides Business Update and Reports First Quarter 2020 Financial Results
4:04pm
PRE 14A
901bam
17 Apr 20
Preliminary proxy
4:18pm
8-K
EX-1.1
gg7svdxo0xz4mj6zymo9
27 Mar 20
Entry into a Material Definitive Agreement
5:19pm
424B5
m2fft0lknyp5in ewt
27 Mar 20
Prospectus supplement for primary offering
5:19pm
8-K
EX-99.1
71xio1k
26 Mar 20
ENDRA Life Sciences Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
4:07pm
8-K
EX-10.2
2cg5kpedu
27 Dec 19
Departure of Directors or Certain Officers
4:06pm